Marcin M. Machnicki

Titin Truncating Variants in Dilated Cardiomyopathy – Prevalence and Genotype-Phenotype Correlations

Maria Franaszczyk, Przemysław Chmielewski, Grażyna Truszkowska et al. · PLoS ONE · 2017 · 91 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors

Silvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed et al. · Blood · 2018 · 75 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Beata Pyrzyńska, Michal Dwojak, Abdessamad Zerrouqi et al. · OncoImmunology · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations

Grażyna Truszkowska, Zofia T. Bilińska, Joanna Kosińska et al. · BMC Medical Genetics · 2015 · 32 citations · Full text

Medicine, Cardiology, Genetics +15

Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells

Wioleta Dudka, Grażyna Hoser, Shamba S. Mondal et al. · BMC Cancer · 2022 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17